We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Large-Scale Genetic Screening Could Identify Populations Vulnerable To COVID-19

By HospiMedica International staff writers
Posted on 19 Aug 2020
French researchers have proposed large-scale genetic screening to identify populations vulnerable to COVID-19, according to a Reuters report. More...


In their hypothesis, the researchers have described two opposing enzyme processes that take place when the coronavirus enters the human body. One process contributes to the infection by helping the virus break into cells, while the other - an opposite process - protects the body by keeping the virus away from its target cells.

According to the researchers, genetic differences among individuals affect the severity of the infection and the strength of the protection mechanisms, with some people having genes that predispose them to infection while others have genes that strengthen the body's protective process. If a genetic risk score were developed based on the information in the genetic databases analyzed by the researchers, then the populations at risk for severe COVID-19 "could be characterized by specific genetic profiles," study co-author Gerard Milano of Antoine Lacassagne Cancer Center (Nice, France) told Reuters.

Related Links:

Antoine Lacassagne Cancer Center


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Gas Analyzer
GE SAM
New
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.